6-fluoro-5-methyl-1-[(1-methylbenzotriazol-5-yl)methyl]-3-(6-oxocyclohexa-1,3-dien-1-yl)indole-2-carboxylic acid
C24H19FN4O3 — CID 58241021
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-fluoro-5-methyl-1-[(1-methylbenzotriazol-5-yl)methyl]-3-(6-oxocyclohexa-1,3-dien-1-yl)indole-2-carboxylic acid
6-fluoro-5-methyl-1-[(1-methylbenzotriazol-5-yl)methyl]-3-(6-oxocyclohexa-1,3-dien-1-yl)indole-2-carboxylic acid (PubChem CID 58241021) has the molecular formula C24H19FN4O3 and a molecular weight of 430.44 g/mol. Its IUPAC name is 6-fluoro-5-methyl-1-[(1-methylbenzotriazol-5-yl)methyl]-3-(6-oxocyclohexa-1,3-dien-1-yl)indole-2-carboxylic acid.
Molecular Properties
| Compound Name | 6-fluoro-5-methyl-1-[(1-methylbenzotriazol-5-yl)methyl]-3-(6-oxocyclohexa-1,3-dien-1-yl)indole-2-carboxylic acid |
|---|---|
| PubChem CID | 58241021 |
| Molecular Formula | C24H19FN4O3 |
| Molecular Weight | 430.44 g/mol |
| Exact Mass | 430.14 |
| IUPAC Name | 6-fluoro-5-methyl-1-[(1-methylbenzotriazol-5-yl)methyl]-3-(6-oxocyclohexa-1,3-dien-1-yl)indole-2-carboxylic acid |
| SMILES | Cc1cc2c(C3=CC=CCC3=O)c(C(=O)O)n(Cc3ccc4c(c3)nnn4C)c2cc1F |
| InChI | InChI=1S/C24H19FN4O3/c1-13-9-16-20(11-17(13)25)29(12-14-7-8-19-18(10-14)26-27-28(19)2)23(24(31)32)22(16)15-5-3-4-6-21(15)30/h3-5,7-11H,6,12H2,1-2H3,(H,31,32) |
| InChIKey | XNYHWZROUPHAPE-UHFFFAOYSA-N |
| XLogP | 4.03 |
| TPSA | 90.01 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 430.44 |
| LogP ≤ 5 | 4.03 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58241021 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.